Stay updated with breaking news from Acumen Diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Core Healthcare Business[1] revenue remains resilient and the Group has a healthy net cashflow from operating activities for 1H23 of $14.2 million, providing cash resources for sustainable growth.- Well-positioned to cater to the rising demand for primary and high value s
- Net cash flow from operating activities more than doubled to S$14.7 million for 1Q2022 from S$6.2 million for 1Q2021.- Reward shareholders with interim dividend of 0.4 Singapore cent per ordinary share
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022
- Acumen Diagnostics will implement swabbing and COVID-19 PCR tests via Q&M Dental's network of outlets to provide accessible, affordable, and convenient testing services- PCR testing services will be
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide